InvestorsHub Logo

elbiatcho1

01/18/17 5:18 PM

#47 RE: T695 #46

Of course it is going lower.

The $100M fine not a big deal, but the forced Synacthen drug competitor will completely wipe out all Acthar.

That's billions down the drain long-term.